SWS
PCVX icon

SYSTM Wealth Solutions’s Vaxcyte PCVX Stock Holding History

SYSTM Wealth Solutions’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-306
Closed -$23.1K – 476
2024
Q2 		$23.1K Hold
306
– – 0.01% 349
2024
Q1 		$20.9K Buy
306
+35
+13% +$2.42K ﹤0.01% 694
2023
Q4 		$17K Buy
+271
New +$14.1K ﹤0.01% 750

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SYSTM Wealth Solutions's PCVX Position: Q3 2024 in Review

SYSTM Wealth Solutions sold out of Vaxcyte (PCVX) in Q3 2024, closing a stake of 306 shares — an estimated $23.1K sold.

SYSTM Wealth Solutions first reported a position in PCVX in Q4 2023 and held it in 3 quarters. The position peaked at $23.1K in Q2 2024. 328 funds tracked by Wall St. Rank hold PCVX as of Q3 2024.

  • SYSTM Wealth Solutions reported no remaining Vaxcyte position as of Q3 2024 after selling out during the quarter.
  • SYSTM Wealth Solutions sold 306 Vaxcyte shares in Q3 2024, an estimated $23.1K.
  • SYSTM Wealth Solutions first reported a position in Vaxcyte in Q4 2023 and held it in 3 quarters.
  • SYSTM Wealth Solutions's Vaxcyte position peaked at $23.1K in Q2 2024.
  • 328 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.